Xyntha 250 IU TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: inert substance, moroctocog alfa
Pack: Xyntha 250 IU (1 x 250 units vial, 1 x 4 mL inert diluent syringe), 1 pack
Brand name
(ARTG)
: XYNTHA moroctocog alfa (rch) 250IU powder for injection plus diluent syringeDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
The control and prevention of haemorrhagic episodes in patients with haemophilia A, including control and prevention of bleeding in surgical settings. XYNTHA does not contain von Willebrand factor and should not be used by patients with von Willebrand's disease.
How to use this medicine
(ARTG)
This medicine is a pack that contains more than one component.
Component :
- Injection, powder for
- Intravenous
- Lyophilised white powder.
Component :
- Diluent, not applicable
- Intravenous
- Clear, colourless solution
Storage conditions
(ARTG)
- Store at 2 to 8 degrees Celsius
- Protect from Light
- Do not Freeze
- Shelf lifetime is 3 Years.
Do I need a prescription ?
(ARTG)
We are unable to tell you if you need a prescription for these medicines. You can ask your pharmacist. This medicine is
- 1 vial powder + 1 pre-filled diluent syringe pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient moroctocog alfa
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
